They usually cause small areas of heavier rotational wind damage among areas of straight-line wind damage. Dust devil
A dust devil (also known as a whirlwind) resembles a tornado in that it is a vertical swirling column of air. However, they form under clear skies and are no stronger than the weakest tornadoes. They form when a strong convective updraft is formed near the ground on a hot day. If there is enough low-level wind shear, the column of hot, rising air can develop a small cyclonic motion that can be seen near the ground. They are not considered tornadoes because they form during fair weather and are not associated with any clouds. However, they can, on occasion, result in major damage. Fire whirls
Small-scale, tornado-like circulations can occur near any intense surface heat source. Those that occur near intense wildfires are called fire whirls. They are not considered tornadoes, except in the rare case where they connect to a pyrocumulus or other cumuliform cloud above. Fire whirls usually are not as strong as tornadoes associated with thunderstorms. They can, however, produce significant damage. Steam devils
A steam devil is a rotating updraft between 50-and-200-metre wide (160 and 660 ft) that involves steam or smoke. These formations do not involve high wind speeds, only completing a few rotations per minute. Steam devils are very rare. They most often form from smoke issuing from a power plants smokestack. Hot springs and deserts may also be suitable locations for a tighter, faster-rotating steam devil to form.
Dapagliflozin/saxagliptin, sold under the brand name Qtern, is a fixed-dose combination anti-diabetic medication used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. It is a combination of dapagliflozin and saxagliptin. It is taken by mouth.The most common side effects include upper respiratory tract infection (such as nose and throat infections) and, when used with a sulphonylurea, hypoglycaemia (low blood glucose levels).Dapagliflozin/saxagliptin was approved for medical use in the European Union in July 2016, and in the United States in February 2017. Medical uses
In the United States dapagliflozin/saxagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.In the European Union it is indicated in adults aged 18 years and older with type 2 diabetes mellitus:

to improve glycemic control when metformin with or without sulphonylurea (SU) and either saxagliptin or dapagliflozin does not provide adequate glycemic control. when already being treated with saxagliptin and dapagliflozin. References
External links
"Dapagliflozin propanediol". Drug Information Portal. U.S. National Library of Medicine. "Saxagliptin". Drug Information Portal. U.S. National Library of Medicine. "Dapagliflozin". MedlinePlus. "Saxagliptin". MedlinePlus.